HR 4733
115th Congress
House
Health
Charitable contributions
Congressional oversight
Department of Health and Human Services
Drug therapy
Drug trafficking and controlled substances
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Income tax credits
Medical research
National Institutes of Health (NIH)
Prescription drugs
Research administration and funding
Research and development
Social work, volunteer service, charitable organizations
User charges and fees
Opioids and STOP Pain Initiative Act
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 3, 2018
Referred to the Subcommittee on Health.
Dec 22, 2017
Referred to the Subcommittee on Health.
Dec 21, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Budget, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 21, 2017
Introduced in House
Plain-English summary
Opioids and STOP Pain Initiative Act
This bill establishes and provides funds for the Opioids and STOP Pain Initiative at the National Institutes of Health (NIH) to support pain-related research, including:
- understanding pain, therapies for chronic pain, and alternatives to opioids for pain treatment as directed in the Comprehensive Addiction and Recovery Act of 2016;
- improving options and evidence for medication-assisted treatment and opioid overdose reversal treatments; and
- supporting the Federal Pain Research Strategy.
NIH must establish the Pain Therapy Screening Program to award grants to support the development of new pre-clinical models for pain disorders, and the application of these models in drug, device, or other therapy screening.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
5